| Acrivon to Highlight Preclinical Data with Three Posters at AACR Demonstrating Strong ACR-368 and ACR-2316 Synergies with Immune Checkpoint Inhibitors and ADC Payloads, Revealing Broad Clinical Development Opportunities |
Globe Newswire |
04/17 |
16:00 |
| Genesis Revival Claims Evaluated: Analyzing the Pineal Gland Support Ingredients, Side Effects Risk and User Complaints |
Globe Newswire |
04/17 |
15:48 |
| MLG Capital Recognized by National Multifamily Housing Council as a 2026 Top 50 Owner |
Globe Newswire |
04/17 |
15:40 |
| NEXGEL Moves Forward Shareholder Update Call to Discuss Celularity Transaction on April 21st at 4:30 P.M. ET |
Globe Newswire |
04/17 |
15:37 |
| Zentalis Pharmaceuticals To Present Azenosertib Preclinical Data in Triple-Negative Breast Cancer and Real-World Analysis of Unmet Need in Cyclin E1-Positive Ovarian Cancer at AACR 2026 |
Globe Newswire |
04/17 |
15:15 |
| Evaxion’s AI-Immunology™ platform demonstrates 86% vaccine target precision in phase 2 personalized cancer vaccine trial |
Globe Newswire |
04/17 |
15:10 |
| Surgery Partners, Inc. Announces First Quarter 2026 Earnings Release Date and Conference Call Details |
Globe Newswire |
04/17 |
15:08 |
| Brazilian Wood Claims Evaluated: Discover the Male Enhancement Hardening Pill Truth by SuperNatural Man |
Globe Newswire |
04/17 |
15:07 |
| Kairos Power Breaks Ground on Hermes 2 Demonstration Plant |
Globe Newswire |
04/17 |
15:06 |
| PRAME-directed Cell Therapy Using Immatics’ TCR Induces Deep and Durable Remission in Pediatric Patient with Advanced Metastatic Nephroblastoma |
Globe Newswire |
04/17 |
15:00 |
| Asgard Therapeutics to present preclinical data on lead asset AT-108, a personalized, off-the-shelf gene therapy, at AACR Annual Meeting 2026 |
Globe Newswire |
04/17 |
15:00 |
| Pheast Therapeutics Reports Initial Phase 1a Data Showing Early Clinical Activity and Target Engagement for PHST001 at AACR 2026 |
Globe Newswire |
04/17 |
15:00 |
| Zymeworks Presents New Preclinical Data at AACR 2026 Highlighting Broad Antibody-Drug Conjugate Programs Including Novel RAS-Targeting Platform |
Globe Newswire |
04/17 |
15:00 |
| MiNK Therapeutics Reports Phase II Data on Immune Reprogramming and Durable Survival in PD-1 Refractory Gastroesophageal Cancer |
Globe Newswire |
04/17 |
15:00 |
| Ohio No. 1 State in the Midwest for Business, According to CEOs Nationwide |
Globe Newswire |
04/17 |
14:47 |
| Toll Brothers Announces Final Luxury Home for Sale at Freestone Station in Marietta, Georgia |
Globe Newswire |
04/17 |
14:45 |
| Unicoin Foundation Debuts, Aligning Social Impact with the Future of Responsible Crypto |
Globe Newswire |
04/17 |
14:44 |
| JimStoppani.com Announces Summer Shred Challenge with $25,000 Grand Prize |
Globe Newswire |
04/17 |
14:40 |
| Dime to Release Earnings on April 23, 2026 |
Globe Newswire |
04/17 |
14:30 |
| U.S. Chamber Discusses How Medical Breakthroughs Are Extending Lives and Strengthening the Economy with YourUpdateTV |
Globe Newswire |
04/17 |
14:27 |
| ImmunityBio Inc. (NASDAQ: IBRX) Investigated for Potential Federal Securities Laws Violations – Lowey Dannenberg, P.C. |
Globe Newswire |
04/17 |
14:08 |
| nVent Electric plc to Report First Quarter 2026 Financial Results on May 1 |
Globe Newswire |
04/17 |
14:00 |
| BitsStrategy Launches an Automated AI Trading Bot to Simplify Smarter, Hands-Free Market Trading |
Globe Newswire |
04/17 |
14:00 |
| Opticore Eye Group Unveils New Contact Lens Program in Riverside, CA for 2026 |
Globe Newswire |
04/17 |
13:57 |
| LeAnn Rimes to Host Virtual Live Event with Human Garage Following Viral Wellness Moment |
Globe Newswire |
04/17 |
13:50 |
